NervGen Pharma Corp.
NGENF
$2.78
$0.176.51%
OTC PK
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 10.07M | 12.00M | 15.55M | 19.41M | 22.38M |
| Total Receivables | 289.10K | 356.20K | 4.80K | 8.40K | 10.00K |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 82.50K | 128.20K | 122.20K | 168.60K | 65.40K |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 266.00K | 728.70K | 566.10K | 389.30K | 514.10K |
| Total Current Assets | 10.71M | 13.21M | 16.24M | 19.97M | 22.97M |
|
|
|||||
| Total Current Assets | 10.71M | 13.21M | 16.24M | 19.97M | 22.97M |
| Net Property, Plant & Equipment | -- | -- | 1.40K | 1.90K | 129.50K |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | 313.80K | 323.10K | 354.50K | 360.10K | 374.30K |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | 5.80K | 24.60K | 42.20K | -- |
| Total Assets | 11.02M | 13.54M | 16.62M | 20.38M | 23.47M |
|
|
|||||
| Total Accounts Payable | -- | -- | 338.50K | 408.80K | 592.90K |
| Total Accrued Expenses | 3.13M | 3.43M | 2.17M | 2.31M | 1.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 56.90K | 67.60K | 70.90K | 69.00K | 68.70K |
| Total Finance Division Other Current Liabilities | 6.86M | 8.24M | 7.22M | 8.42M | 6.90M |
| Total Other Current Liabilities | 6.86M | 8.24M | 7.22M | 8.42M | 6.90M |
| Total Current Liabilities | 10.05M | 11.75M | 9.81M | 11.21M | 9.51M |
|
|
|||||
| Total Current Liabilities | 10.05M | 11.75M | 9.81M | 11.21M | 9.51M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | 5.80K | 24.60K | 42.20K | 60.40K |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 10.05M | 11.75M | 9.83M | 11.25M | 9.57M |
|
|
|||||
| Common Stock & APIC | 57.34M | 56.36M | 59.59M | 58.48M | 58.92M |
| Retained Earnings | -73.82M | -71.00M | -69.25M | -64.53M | -59.45M |
| Treasury Stock & Other | 17.45M | 16.43M | 16.45M | 15.18M | 14.43M |
| Total Common Equity | 966.70K | 1.79M | 6.79M | 9.13M | 13.90M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 966.70K | 1.79M | 6.79M | 9.13M | 13.90M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 966.70K | 1.79M | 6.79M | 9.13M | 13.90M |
|
|
|||||